Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Hyllner

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 30, 2015
Cells: from Robert Hooke to cell therapy--a 350 year journeyJohan Hyllner, Chris Mason, Ian Wilmut
Stem Cell Reviews and Reports|January 22, 2010
Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applicationsHilmar Vidarsson, Johan Hyllner, Peter Sartipy
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
Single cell enzymatic dissociation of human embryonic stem cells: a straightforward, robust, and standardized culture methodCatharina Ellerström, Johan Hyllner, Raimund Strehl
Recent Patents on Nanotechnology|December 17, 2008
Trends in the human embryonic stem cell patent fieldUlrika Karlsson, Johan Hyllner, Kristina Runeberg
Current Opinion in Drug Discovery & Development|January 20, 2009
Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discoveryDaniella Steel, Johan Hyllner, Peter Sartipy
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Labeled stem cells as disease models and in drug discoveryCatharina Ellerström, Raimund Strehl, Johan Hyllner
Journal of Cellular Physiology|March 12, 2009
Human embryonic stem cell technologies and drug discoveryJanne Jensen, Johan Hyllner, Petter Björquist
Idrugs : the Investigational Drugs Journal|October 4, 2006
Pluripotent human stem cells as novel tools in drug discovery and toxicity testingPeter Sartipy, Petter Bjorquist, Raimund Strehl, et al.
Pharmacological Research|July 1, 2008
Low molecular weight compounds for in vitro fate determination of human embryonic stem cellsPeter Sartipy, Raimund Strehl, Petter Björquist, et al.
Drug Discovery Today|September 11, 2007
The application of human embryonic stem cell technologies to drug discoveryPeter Sartipy, Petter Björquist, Raimund Strehl, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 30, 2015
Cells: from Robert Hooke to cell therapy--a 350 year journeyJohan Hyllner, Chris Mason, Ian Wilmut
Stem Cell Reviews and Reports|January 22, 2010
Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applicationsHilmar Vidarsson, Johan Hyllner, Peter Sartipy
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2009
Single cell enzymatic dissociation of human embryonic stem cells: a straightforward, robust, and standardized culture methodCatharina Ellerström, Johan Hyllner, Raimund Strehl
Recent Patents on Nanotechnology|December 17, 2008
Trends in the human embryonic stem cell patent fieldUlrika Karlsson, Johan Hyllner, Kristina Runeberg
Current Opinion in Drug Discovery & Development|January 20, 2009
Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discoveryDaniella Steel, Johan Hyllner, Peter Sartipy
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Labeled stem cells as disease models and in drug discoveryCatharina Ellerström, Raimund Strehl, Johan Hyllner
Journal of Cellular Physiology|March 12, 2009
Human embryonic stem cell technologies and drug discoveryJanne Jensen, Johan Hyllner, Petter Björquist
Idrugs : the Investigational Drugs Journal|October 4, 2006
Pluripotent human stem cells as novel tools in drug discovery and toxicity testingPeter Sartipy, Petter Bjorquist, Raimund Strehl, et al.
Pharmacological Research|July 1, 2008
Low molecular weight compounds for in vitro fate determination of human embryonic stem cellsPeter Sartipy, Raimund Strehl, Petter Björquist, et al.
Drug Discovery Today|September 11, 2007
The application of human embryonic stem cell technologies to drug discoveryPeter Sartipy, Petter Björquist, Raimund Strehl, et al.
Pageof 5